These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26041986)

  • 1. Therapeutic benefits of nanoparticles in stroke.
    Panagiotou S; Saha S
    Front Neurosci; 2015; 9():182. PubMed ID: 26041986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology based diagnostic and therapeutic strategies for neuroscience with special emphasis on ischemic stroke.
    Nair SB; Dileep A; Rajanikant GK
    Curr Med Chem; 2012; 19(5):744-56. PubMed ID: 22204347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of nanoparticles for neuroprotection in acute ischemic stroke.
    Chen L; Gao X
    Ther Deliv; 2017 Oct; 8(10):915-928. PubMed ID: 28944741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
    Liu S; Feng X; Jin R; Li G
    Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
    Fukuta T; Oku N; Kogure K
    Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
    Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y
    J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal nanoprobes evaluating physiological pore size of brain vasculatures in ischemic stroke models.
    Zheng S; Bai YY; Changyi Y; Gao X; Zhang W; Wang Y; Zhou L; Ju S; Li C
    Adv Healthc Mater; 2014 Nov; 3(11):1909-18. PubMed ID: 24898608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.
    Fukuta T; Asai T; Yanagida Y; Namba M; Koide H; Shimizu K; Oku N
    FASEB J; 2017 May; 31(5):1879-1890. PubMed ID: 28082354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
    Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
    CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
    Fukuta T; Ishii T; Asai T; Oku N
    Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery.
    Zhang S; Peng B; Chen Z; Yu J; Deng G; Bao Y; Ma C; Du F; Sheu WC; Kimberly WT; Simard JM; Coman D; Chen Q; Hyder F; Zhou J; Sheth KN
    Bioact Mater; 2022 Oct; 16():57-65. PubMed ID: 35386312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in nanoparticle-based therapeutics for ischemic stroke: Enhancing drug delivery and efficacy.
    Ji P; Xu Q; Li J; Wang Z; Mao W; Yan P
    Biomed Pharmacother; 2024 Nov; 180():117564. PubMed ID: 39405899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
    Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
    Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural stem cell therapy for subacute and chronic ischemic stroke.
    Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
    Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y; Shimura H; Tanaka R; Yamashiro K; Koike M; Uchiyama Y; Urabe T; Hattori N
    PLoS One; 2018; 13(5):e0198039. PubMed ID: 29795667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Approaches in Nanomedicine for Ischemic Stroke.
    Correa-Paz C; da Silva-Candal A; Polo E; Parcq J; Vivien D; Maysinger D; Pelaz B; Campos F
    Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of thrombolytic therapy and neuroprotective therapy in acute ischemic stroke: is it important?
    Wang Y; Li Q; Wang J; Zhuang QK; Zhang YY
    Eur Rev Med Pharmacol Sci; 2015; 19(3):416-22. PubMed ID: 25720713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient brain hypothermia reduces the reperfusion injury of delayed tissue plasminogen activator and extends its therapeutic time window in a focal embolic stroke model.
    Zarisfi M; Allahtavakoli F; Hassanipour M; Khaksari M; Rezazadeh H; Allahtavakoli M; Taghavi MM
    Brain Res Bull; 2017 Sep; 134():85-90. PubMed ID: 28710023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.